Experienced in Alpha-1 Antitrypsin Deficiency (AATD)

Rob A. Janssen

Canisius Wilhelmina Ziekenhuis
Nijmegen, GE, NL 
Experienced in Alpha-1 Antitrypsin Deficiency (AATD)
Canisius Wilhelmina Ziekenhuis
Nijmegen, GE, NL 
OverviewLocationsClinical Research

Overview

Rob Janssen practices in Nijmegen, Netherlands. Janssen is rated as an Experienced expert by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). Their top areas of expertise are Emphysema, Chronic Obstructive Pulmonary Disease (COPD), Malnutrition, Knee Replacement, and Endoscopy.

Their clinical research consists of co-authoring 100 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Alpha-1 Antitrypsin Deficiency (AATD).

Locations

Canisius Wilhelmina Ziekenhuis
Nijmegen, GE, Netherlands

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

The PREDMETH Trial: Effectiveness of Methotrexate Versus Prednisone as First-line Therapy for Pulmonary Sarcoidosis - A Randomized Controlled Trial
The PREDMETH Trial: Effectiveness of Methotrexate Versus Prednisone as First-line Therapy for Pulmonary Sarcoidosis - A Randomized Controlled Trial
Enrollment Status: Active_not_recruiting
Publish Date: March 26, 2025
Intervention Type: Drug
Study Drugs: Methotrexate, Prednisolone
Study Phase: Phase 4
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: August 12, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
Santeon-CAP; Dexamethasone in Community-acquired Pneumonia.
Santeon-CAP; Dexamethasone in Community-acquired Pneumonia.
Enrollment Status: Terminated
Publish Date: April 18, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 3 Less Clinical Trials

100 Total Publications

Evaluation of a curved intramedullary button vs. traditional flat button for proximal biceps tenodesis: a biomechanical study.
Evaluation of a curved intramedullary button vs. traditional flat button for proximal biceps tenodesis: a biomechanical study.
Journal: JSES international
Published: September 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Janssen's expertise for a condition
ConditionClose
    View All 20 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile